論文・総説 - 末永　光邦

221. Kuboki Yasutoshi, Mizunuma Nobuyuki, Ozaka Masato, Ogura Mariko, Suenaga Mitsukuni, Shinozaki Eiji, Matsusaka Satoshi, Chin Keishou, Matsuura Masaaki, Hatake Kiyohiko. Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer ONCOLOGY LETTERS. 2011; 2 (3): 493-498. ( PubMed, DOI )

222. Oba Masaru, Chin Keisho, Kawazoe Yoshimasa, Takagi Koichi, Ogura Mariko, Shinozaki Eiji, Suenaga Mitsukuni, Matsusaka Satoshi, Mizunuma Nobuyuki, Hatake Kiyohiko. Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of fluoropyrimidine-based regimens ONCOLOGY LETTERS. 2011; 2 (2): 241-245. ( PubMed, DOI )

223. Matsusaka Satoshi, Mishima Yuji, Mizunuma Nobuyuki, Suenaga Mitsukuni, Shinozaki Eiji, Chin Keisho, Ogura Mariko, Osaka Masato, Takagi Koichi, Watanabe Toshiyasu, Nozaki Akira, Oba Masaru, Kawazoe Yoshimasa, Terui Yasuhito, Hatake Kiyohiko. CEP AND CXCR4+CEC ARE PREDICTIVE MARKERS FOR BEVACIZUMAB CONTAINING CHEMOTHERAPY IN MCRC ANNALS OF ONCOLOGY. 2010.11; 21 13.

224. Suenaga Mitsukuni, Mizunuma Nobuyuki, Shinozaki Eiji, Matsusaka Satoshi, Chin Keisho, Kuboki Yasutoshi, Watanabe Toshiyasu, Fujimoto Yoshiya, Ueno Masashi, Kuroyanagi Hiroya, Oya Masatoshi, Yamamoto Noriko, Hatake Kiyohiko. CONTINUATION OF OXALIPLATIN IS A POTENTIAL PREDICTIVE FACTOR IN ADJUVANT FOLFOX FOR STAGE IIIB OR IV COLORECTAL CANCER ANNALS OF ONCOLOGY. 2010.11; 21 30.

225. Watanabe Toshiyasu, Shinozaki Eiji, Asai Hiroaki, Kuboki Yasutoshi, Oto Masafumi, Kawazoe Yoshimasa, Nozaki Akira, Takagi Kouichi, Ozaka Masato, Ogura Mariko, Suenaga Mitsukuni, Matsusaka Satoshi, Chin Keisho, Mizunuma Nobuyuki, Hatake Kiyohiko. CETUXIMAB INDUCED ACNE LIKE ERUPTION MIGHT BE MILD IN ELDERLY PATIENTS GROUP ANNALS OF ONCOLOGY. 2010.11; 21 31.

226. Shinozaki Eiji, Mizunuma Nobuyuki, Asai Hiroaki, Watanabe Toshiyasu, Nozaki Akira, Matsusaka Satoshi, Suenaga Mitsukuni, Chin Keisho, Ogura Mariko, Osaka Masato, Kuboki Yasutoshi, Takagi Koichi, Ichimura Takashi, Hatake Kiyohiko. EARLY SERUM MAGNESIUM REDUCTION MAY REPRESENT THE DISEASE CONTROL IN METASTATIC COLORECTAL CANCER TREATED WITH CETUXIMAB ANNALS OF ONCOLOGY. 2010.11; 21 33.

227. Kuboki Yasutoshi, Shinozaki Eiji, Ichimura Takashi, Ozaka Masato, Oba Masaru, Ogura Mariko, Suenaga Mitukuni, Matusaka Satoshi, Chin Keishou, Mizunuma Nobuyuki, Hatake Kiyohiko. GRADE 2 AND OVER DIGESTIVE TOXICITY IS AN UNFEASIBLE CAUSE OF OUTPATIENT-BASED CDDP IN ADVANCED/RECURRENT GASTRIC CANCER ANNALS OF ONCOLOGY. 2010.11; 21 28.

228. Kawazoe Yoshimasa, Shinozaki Eiji, Hosonaga Mari, Kuboki Yasutoshi, Ichimura Takashi, Watanabe Toshiyasu, Oba Masaru, Takagi Koichi, Ozaka Masato, Ogura Mariko, Suenaga Mitsukuni, Matsusaka Satoshi, Chin Keisho, Mizunuma Nobuyuki, Hatake Kiyohiko. FOLFOX COULD INDUCE SPLENOMEGALY, WHICH MIGHT WORSEN THROMBOCYTOPENIA ANNALS OF ONCOLOGY. 2010.11; 21 34.

229. Chin Keisho, Yoshimoto Kazuhito, Mizunuma Nobuyuki, Matsusaka Satoshi, Shinozaki Eiji, Suenaga Mitsukuni, Ogura Mariko, Ozaka Masato, Kuboki Yasuhito, Ichimura Takashi, Takagi Koichi, Nozaki Akira, Watanabe Toshiyasu, Hatake Kiyohiko. ENDOSCOPIC EVALUATION OF THE PRIMARY TUMOR CONCERNING OF THE EFFICACY OF CHEMOTHERAPY FOR ADVANCED GASTRIC CANCER ANNALS OF ONCOLOGY. 2010.11; 21 28.

230. Takagi Koichi, Chin Keisho, Oba Masaru, Kuboki Yasutoshi, Oto Masafumi, Ichimura Takashi, Kawazoe Yoshimasa, Watanabe Toshiyasu, Ozaka Masato, Ogura Mariko, Suenaga Mitsukuni, Shinozaki Eiji, Matsusaka Satoshi, Mizunuma Nobuyuki, Hatake Kiyohiko. EFFICACY OF PACLITAXEL FOR S-1-REFRACTORY GASTRIC CANCER ANNALS OF ONCOLOGY. 2010.11; 21 28-29.

231. Ogura Mariko, Matsusaka Satoshi, Kuboki Yasutoshi, Takashi Ichimura, Watanabe Toshiyasu, Takagi Kouichi, Nozaki Akira, Ozaka Masato, Shinozaki Eiji, Suenaga Mitsukuni, Chin Keisyou, Mizunuma Nobuyuki, Hatake Kiyohiko. EFFICACY OF FOLFOX4 REJIMEN FOR METASTATIC COLORECTAL CANCER ANNALS OF ONCOLOGY. 2010.11; 21 30.

232. Mizunuma Nobuyuki, Shinozaki Eiji, Suenaga Mitsukuni, Matsusaka Satoshi, Kuboki Yasutoshi, Nozaki Akira, Takagi Kouichi, Watanabe Toshiyasu, Kawazoe Yoshimasa, Hatake Kiyohiko. METASTATIC COLORECTAL CANCER ADVANCES IN CHEMOTHERAPY; THE REVIEW OF FOR 10 YEARS IN ARIAKE CANCER INSTITUTE ANNALS OF ONCOLOGY. 2010.11; 21 15.

233. Asai Hiroaki, Shinozaki Eiji, Mizunuma Nobuyuki, Watanabe Toshiyasu, Nozaki Akira, Kuboki Yasutoshi, Ichimura Takashi, Takagi Koichi, Ozaka Masato, Ogura Mariko, Suenaga Mitsukuni, Matsuzaka Satoshi, Chin Keisho, Hatake Kiyohiko. RESPONSE TO CETUXIMAB CONTAINING CHEMOTHERAPY WAS RELATED WITH LONGER TTF:RETROSPECTIVE ANALYSIS OF 72 PATIENTS ANNALS OF ONCOLOGY. 2010.11; 21 33.

234. Oto Masafumi, Shinozaki Eiji, Kuboki Yasutoshi, Ichimura Taksahi, Watanabe Toshiyasu, Takagi Koichi, Ozaka Masato, Ogura Mariko, Suenaga Mitsukuni, Matsusaka Satoshi, Chin Keisho, Mizunuma Nobuyuki, Hatake Kiyohiko, Yamamoto Chiriko. SERUM P53 ANTIBODY IN PATIENTS WITH ESOPAHAGEAL CANCER TREATED WITH CURATIVE CHEMORADIOTERAPY(CRT) IS NOT PREDICTIVE ANNALS OF ONCOLOGY. 2010.11; 21 27-28.

235. Nozaki Akira, Shinozaki Eiji, Watanabe Toshiyasu, Takagi Koichi, Ichimura Takashi, Kuboki Yasutoshi, Ozaka Masato, Ogura Mariko, Matsuzaka Satoshi, Suenaga Mitsukuni, Chin Keisho, Mizunuma Nobuyuki, Hatake Kiyohiko, Matsuura Masaaki, Ushijima Masaru. WHAT HINDERS THE 3RD LINE CHEMOTHERAPY IN COLORECTAL CANCER PATIENTS? ANNALS OF ONCOLOGY. 2010.11; 21 31.

236. Watanabe Toshiyasu, Suenaga Mitsukuni, Kuboki Yasutoshi, Ichimura Takashi, Kawazoe Yoshimasa, Nozaki Akira, Ooba Masaru, Takagi Kouichi, Ozaka Masato, Ogura Mariko, Shinozaki Eiji, Matsusaka Satoshi, Chin Keisho, Mizunuma Nobuyuki, Hatake Kiyohiko. THE REASON WHY PATIENTS COULD NOT COMBINE BEVACIZUMAB IN METASTATIC COLORECTAL CANCER ANNALS OF ONCOLOGY. 2010.11; 21 15.

237. Ozaka Masato, Kuboki Yasutoshi, Ichimura Takashi, Kawazoe Yoshimasa, Watanabe Toshiyasu, Takagi Koichi, Oba Masaru, Ogura Mariko, Shinozaki Eiji, Suenaga Mitsukuni, Matsusaka Satoshi, Chin Keisho, Mizunuma Nobuyuki, Hatake Kiyohiko. THE OPTIMAL TIME FOR SURGERY AFTER RECEIVING IMATINIB IN GIST PATIENTS: A RETROSPECTIVE ANALYSIS ANNALS OF ONCOLOGY. 2010.11; 21 18-19.

238. Yukisawa S., Fujiwara Y., Yamamoto Y., Ueno T., Matsueda K., Kohno A., Suenaga M.. Upper-extremity deep vein thrombosis related to central venous port systems implanted in cancer patients BRITISH JOURNAL OF RADIOLOGY. 2010.10; 83 (994): 850-853. ( DOI )

239. Suenaga Mitsukuni, Mizunuma Nobuyuki, Kobayashi Kokoro, Shinozaki Eiji, Matsusaka Satoshi, Chin Keisho, Kuboki Yasutoshi, Ichimura Takashi, Ozaka Masato, Ogura Mariko, Fujiwara Yoshimasa, Matsueda Kiyoshi, Konishi Fumio, Hatake Kiyohiko. Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab MEDICAL ONCOLOGY. 2010.09; 27 (3): 807-814. ( PubMed, DOI )

240. Suenaga M., Matsusaka S., Takagi K., Kuboki Y., Watanabe T., Shinozaki E., Chin K., Mizunuma N., Hatake K.. Potential markers predicting bevacizumab efficacy for metastatic colorectal cancer patients. JOURNAL OF CLINICAL ONCOLOGY. 2010.05; 28 (15):